降钙素
医学
甲状腺
破骨细胞
骨吸收
内分泌学
内科学
激素
恶性肿瘤
钙
骨质疏松症
受体
作者
Angela M. Inzerillo,Mone Zaidi,Christopher Huang
出处
期刊:Thyroid
[Mary Ann Liebert, Inc.]
日期:2002-09-01
卷期号:12 (9): 791-798
被引量:42
标识
DOI:10.1089/105072502760339352
摘要
Calcitonin was originally discovered as a hypocalcemic factor synthesized by thyroid parafollicular C cells. Early experiments demonstrated that calcitonin inhibited bone resorption and decreased calcium efflux from isolated cat tibiae and subsequent histologic and culture studies confirmed the osteoclast as its major site of action. Its potent antiresorptive effect and analgesic action have led to its clinical use in treatment of Paget's bone disease, osteoporosis, and hypercalcemia of malignancy. This review surveys the cellular and molecular basis of these physiologic and clinical actions.
科研通智能强力驱动
Strongly Powered by AbleSci AI